Comparative Studies | Medical Science | India | Volume 8 Issue 9, September 2019
Mitomycin C versus Ologen Implant in Primary Trabeculectomy: A Comparative Study
Abstract: AIM: To assess and compare the efficacy of mitomycin c versus ologen implant in trabeculectomy METHODS: In this study, 21 pateints of POAG underwent trabeculectomy with ologen implant (group A) and 21 patients of POAG underwent trabeculectomy with MMC (group B). Postoperative IOP, BCVA, need for antiglaucoma medications, complications were noted at day 1 and 7, 4 week, 12 week and 6 month. RESULTS: The mean pre operative IOP in group A was 27.05 ± 4.30 mm Hg and 26.72 ± 4.47 mm Hg in group B. At six months follow up the post operative mean IOP was 13.23 ± 4.28 mm Hg in group A and 13.66 ± 4.39 mm Hg in group B which was not statistically significant. Post operative complications in the two groups was found to be not significant (p = 0.198). Postoperative mean BCVA (in log mar) in group A was 0.6 and 0.68 in group B which was not significant. CONCLUSION: The success and complications rate of trabeculectomy were similar in both Ologen and MMC groups at the end of 6 months.
Keywords: MMC, Trabeculectomy, ologen implant
Edition: Volume 8 Issue 9, September 2019,
Pages: 1733 - 1736
How to Cite this Article?
Dr. Ankur Kumar, Dr. Shalini Dhiman, Dr. Kishor Kumar, "Mitomycin C versus Ologen Implant in Primary Trabeculectomy: A Comparative Study", International Journal of Science and Research (IJSR), Volume 8 Issue 9, September 2019, pp. 1733-1736, https://www.ijsr.net/get_abstract.php?paper_id=ART20201385
How to Share this Article?
Similar Articles with Keyword 'MMC'
In World First Transplant; A Man Received Genetically-Modified Pig Heart
To Study the Long Term Effects on Centrtal Corneal Thickness with Mitomycin C Augmented Trabeculectomy Vs Trabecuelectomy without Mitomycin C in Primary Glaucoma: A Comparative Study